HomeComparePTKFF vs BTI

PTKFF vs BTI: Dividend Comparison 2026

PTKFF yields 3.72% · BTI yields 5.40%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PTKFF wins by $1.5K in total portfolio value· pulled ahead in Year 9
10 years
PTKFF
PTKFF
● Live price
3.72%
Share price
$0.06
Annual div
$0.00
5Y div CAGR
19.5%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$39.3K
Annual income
$3,967.70
Full PTKFF calculator →
BTI
BTI
● Live price
5.40%
Share price
$58.26
Annual div
$3.15
5Y div CAGR
11.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$37.8K
Annual income
$2,802.29
Full BTI calculator →

Portfolio growth — PTKFF vs BTI

📍 PTKFF pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPTKFFBTI
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PTKFF + BTI cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PTKFF pays
BTI pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PTKFF
Annual income on $10K today (after 15% tax)
$316.37/yr
After 10yr DRIP, annual income (after tax)
$3,372.54/yr
BTI
Annual income on $10K today (after 15% tax)
$459.05/yr
After 10yr DRIP, annual income (after tax)
$2,381.95/yr
At 15% tax rate, PTKFF beats the other by $990.60/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PTKFF + BTI for your $10,000?

PTKFF: 50%BTI: 50%
100% BTI50/50100% PTKFF
Portfolio after 10yr
$38.5K
Annual income
$3,384.99/yr
Blended yield
8.78%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

PTKFF
No analyst data
Altman Z
8.5
Piotroski
6/9
BTI
Analyst Ratings
12
Buy
4
Hold
2
Sell
Consensus: Buy
Price Target
$40.00
-31.3% upside vs current
Range: $40.00 — $40.00
Altman Z
2.1
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PTKFF buys
0
BTI buys
0
No recent congressional trades found for PTKFF or BTI in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPTKFFBTI
Forward yield3.72%5.40%
Annual dividend / share$0.00$3.15
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR19.5%11.3%
Portfolio after 10y$39.3K$37.8K
Annual income after 10y$3,967.70$2,802.29
Total dividends collected$16.2K$14.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: PTKFF vs BTI ($10,000, DRIP)

YearPTKFF PortfolioPTKFF Income/yrBTI PortfolioBTI Income/yrGap
1$11,145$444.78$11,301$601.08$156.00BTI
2$12,479$553.61$12,799$706.58$320.00BTI
3$14,044$692.28$14,527$832.38$483.00BTI
4$15,898$870.16$16,527$982.75$629.00BTI
5$18,110$1,100.06$18,846$1,162.95$736.00BTI
6$20,778$1,399.58$21,545$1,379.49$767.00BTI
7$24,026$1,793.30$24,694$1,640.41$668.00BTI
8$28,023$2,315.85$28,378$1,955.69$355.00BTI
9← crossover$33,001$3,016.74$32,702$2,337.79+$299.00PTKFF
10$39,279$3,967.70$37,794$2,802.29+$1.5KPTKFF

PTKFF vs BTI: Complete Analysis 2026

PTKFFStock

PT Kalbe Farma Tbk., together with its subsidiaries, develops, manufactures, and trades in pharmaceutical products in Indonesia. The company operates through four divisions: Prescription Pharmaceuticals, Consumer Health, Nutritionals, and Distribution and Logistic. It offers generic, branded, and licensed drugs, including Brainact, Cefspan, Mycoral, Cernevit, Cravit, Neuralgin, Broadced, Neurotam, Hemapo, and CPG that are distributed to hospitals, pharmacies, and drug stores. The company also provides over-the-counter drugs; energy drinks, ready-to-drink products, supplements, and other preventive products; and nutritional products for infants, toddlers, children, teenagers, adults, pregnant and lactating women, and elders, as well as for consumers with special medical needs. In addition, it offers contract services, including clinical study management, bioavailability/bioequivalence studies, and contract analysis to pharmaceutical companies; and animal health products, as well as operates Mitrasana Clinics, a health care service. Further, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. PT Kalbe Farma Tbk. was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

Full PTKFF Calculator →

BTIConsumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →
📬

Get this PTKFF vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PTKFF vs SCHDPTKFF vs JEPIPTKFF vs OPTKFF vs KOPTKFF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.